Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Erb-b2 receptor tyrosine kinase 2 gene (ERBB2 or HER2) alterations are found in approximately 2-5% of non-small cell lung cancers (NSCLCs); the majority are...

  • 1638193747241603072 Profile photo of Madelyn

    Poziotinib in Treatment-Naïve HER2 Ex 20 Mutations: ZENITH20-4- Ph2 @JTOonline - N=80 - ORR 39%; DCR 73%; mPFS 5.6m - TRAEs: rash 45% stomatitis, diarrhea 15% - ⬆️ORR 71% in G778_P780dupGS ➡️ FDA declined 2nd line approval in 2022 pending more data #lcsm https://t.co/6CuMFdBTPk - view on twitter

Mashup Score:12


IASLC Lightning Member Portal - 1 week

Mashup Score:12

Loading×Sorry to interruptCSS...

  • 1638548648261832706 Profile photo of Madelyn

    Join us in 2 weeks at #SCLC23! A meeting focused on preclinical/clinical advances in #SCLC research, including basic research on oncogenesis & biology of disease, preclinical therapeutic research & highlights of ongoing clinical translation. Register https://t.co/bn7tcPelLA #LCSM https://t.co/bn7tcPelLA - view on twitter

Mashup Score:11


Texas Lung Cancer Conference | IASLC - 7 days

Mashup Score:11

We are excited to invite you to join us at the 1st Annual Texas Lung Cancer Conference in Austin, TX at the historic Austin...

  • 1639281325210230784 Profile photo of Madelyn

    Next week join the 1st Annual #TexasLung23 in Austin, TX @ the historic Austin City Limits. This 2-day CME-event will review the latest advances in #lungcancer focused on what a medical oncologist needs to know to provide state–of–the art care today. https://t.co/9ggoUVnvnP #LCSM https://t.co/9ggoUVnvnP - view on twitter

Mashup Score:11


LUNGSTONG | 5k Run - 2 days

Mashup Score:11

Each year hundreds of runners and walkers come out in support of lung cancer research at this family-friendly event. 100% of race proceeds benefit...

Stephen Liu, MD, and Tina Cascone, MD, PhD, share what attendees can expect at the first ever Texas Lung Cancer Conference, an upcoming two-day...

Durvalumab maintenance therapy following definitive concurrent chemoradiotherapy (CRT) is the standard treatment modality for stage III non-small cell lung cancer (NSCLC). Although severe treatment-related...

Mashup Score:10


In this episode of Lung Cancer Considered, recorded at the 2023 Targeted Therapies of Lung Cancer meeting, host Dr. Narjust Florez moderates a conversation...

ClinicalTrials.gov Identifiers: NCT02367781, NCT02657434, and...

Participation in lung cancer screening (LCS) is lower in populations with the highest burden of lung cancer risk (through the social patterning of smoking...

IASLC – STARS Scholar - 4 days

Mashup Score:7

ALL INTERESTED PATIENT ADVOCATES: Please join us March 28 @ 10 AM MDT for a Zoom session where Janet Freeman-Daily (IASLC STARS Staff Consultant),...

  • 1640323048287903747 Profile photo of Madelyn

    Deadline Approaching! Apply by 4/2 for the STARS Scholars Program! A new opportunity for PRAs who want to attend #WCLC23 in person & have demonstrated active participation in PR advocacy activities. Learn more about the STARS Scholar program & Apply: https://t.co/DCVYfRwPD4 #LCSM https://t.co/DCVYfRwPD4 - view on twitter